- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Fanapt
Synonyms :
iloperidone
Class :
Antipsychotics, 2nd Generation
Dosage forms & Strengths:
Tablet
1 mg
2 mg
4 mg
6 mg
8 mg
10 mg
12 mg
Safety and efficacy are not seen in pediatrics
may enhance the serum concentration of CYP3A4 inhibitors
they decrease the concentration of active metabolites of iloperidone in the serum
they decrease the concentration of active metabolites of iloperidone in the serum
they decrease the concentration of active metabolites of iloperidone in the serum
they decrease the concentration of active metabolites of iloperidone in the serum
they decrease the concentration of active metabolites of iloperidone in the serum
when both drugs are combined, there may be an increased risk or severity of QTC prolongation
QTc interval is increased both by lenvatinib and iloperidone
may increase the QTc interval when combined
may enhance the hypotensive effect of Blood Pressure Lowering Agents
may enhance the hypotensive effect of Blood Pressure Lowering Agents
may enhance the hypotensive effect of Blood Pressure Lowering Agents
may enhance the hypotensive effect of Blood Pressure Lowering Agents
may enhance the hypotensive effect of Blood Pressure Lowering Agents
thrombolytic Agents may enhance the adverse/toxic effect of prostacyclin Analogues
may enhance the adverse/toxic effect of anticoagulants
may enhance the adverse/toxic effect of anticoagulants
may enhance the adverse/toxic effect of anticoagulants
may enhance the adverse/toxic effect of anticoagulants
may enhance the adverse/toxic effect of anticoagulants
may have an increased antiplatelet effect when combined with antiplatelet agents
may have an increased antiplatelet effect when combined with antiplatelet agents
may have an increased antiplatelet effect when combined with antiplatelet agents
may have an increased antiplatelet effect when combined with antiplatelet agents
may have an increased antiplatelet effect when combined with antiplatelet agents
may have an increased adverse effect when combined with anticoagulants
may have an increased adverse effect when combined with anticoagulants
may have an increased adverse effect when combined with anticoagulants
may have an increased adverse effect when combined with anticoagulants
may have an increased adverse effect when combined with anticoagulants
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased adverse effect when combined with prostacyclin analogues
It may enhance sedation when combined with a shepherd's purse
It may diminish the effects when combined with chasteberry by pharmacodynamic antagonism
may have an increased hypotensive effect when combined with antihypertensive drugs
prostacyclin analogues: they may increase the hypotensive effect when combined with blood viscosity-reducing agents
prostacyclin analogues: they may increase the hypotensive effect when combined with blood viscosity-reducing agents
prostacyclin: they may increase the antiplatelet effect of antiplatelet agents
prostacyclin: they may increase the antiplatelet effect of antiplatelet agents
it increases the effect or level of palbociclib by altering the intestinal or hepatic CYP3A4 enzyme metabolism
may increase the level of effectiveness through P-glycoprotein MDR1 efflux transporter
relugolix/estradiol/norethindrone
it decreases by affecting the hepatic enzyme CYP3A4 metabolism
may increase the hypotensive effect of antihypertensives
may enhance the toxic effect of anti-coagulants
may increase the hypotensive effect of calcium channel blockers
may increase the hypotensive effect of calcium channel blockers
lisinopril/hydrochlorothiazide
may increase the hypotensive effect of blood pressure-lowering agents
eprosartan/hydrochlorothiazide
may increase the hypotensive effect of blood pressure-lowering agents
may increase the hypotensive effect of blood pressure-lowering agents
may increase the antiplatelet effect of antiplatelet agents
may have an increased hypotensive effect when combined with antihypertensive agents
may have an increased hypotensive effect when combined with antihypertensive agents
may have an increased hypotensive effect when combined with antihypertensive agents
may have an increased hypotensive effect when combined with antihypertensive agents
may have an increased hypotensive effect when combined with antihypertensive agents
may increase the hypotensive effect of Blood Pressure Lowering Agents
may increase the hypotensive effect of Blood Pressure Lowering Agents
may increase the hypotensive effect of Blood Pressure Lowering Agents
may decrease the hypotensive effect of Blood Pressure Lowering Agents
It may diminish the metabolism when combined with Heparins
It may diminish the metabolism when combined with Heparins
It may diminish the metabolism when combined with Heparins
>10%:
Dizziness
Dry mouth
Nausea
Somnolence
Tachycardia
1-10%:
Ejaculation failure
Diarrhea
Myalgia
Palpitations
Nasal congestion
Weight gain
Urinary incontinence
<1%:
Edema
Amenorrhea
Hypothyroidism
Frequency undefined:
Priapism
Iloperidone is contraindicated in patients hypersensitive to the active ingredient.
Pregnancy consideration:
Category C
Breastfeeding warnings:
No data is available regarding the excretion of the drug in breast milk.
Pregnancy category:
Patient information leaflet
Generic Name: iloperidone
Pronounced: ilo-PER-i-done
Why do we use iloperidone?
Iloperidone is a second-generation antipsychotic. It is used to reverse the effect of general anesthesia. It is used to treat schizophrenia.